In cell culture, breast cancer cells with secondary resistance to trastuzumab displayed an up-regulation of mRNA expression for EGF, TGFα, HB-EGF and heregulin, while the expression of AREG mRNA was downregulated and the expression of epiregulin and betacellulin mRNA was unchanged. This evidence concerns the gene AREG and breast cancer.